Let's break down the importance of its Amazon deal and analyze what the business is still struggling with to ... But an even ...

With transformation efforts, M&As and revenue diversification expected to boost the healthcare market, should investors ...

On that note, Terns Pharmaceuticals ( TERN -5.84%) is a biotech developing weight loss therapies that's worth investing ...

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized ...

ATI Physical Therapy, Inc. (ATIP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or ...

Bicara Therapeutics, a TPG-backed biopharmaceutical company developing a therapy targeting tumors, said on Wednesday it plans ...

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on ESSA Pharma (EPIX – Research Report), with a price ...

Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on IO Biotech (IOBT – Research Report). The associated price ...

Fulcrum Therapeutics said on Thursday its experimental drug to treat a type of genetic muscle disorder failed to meet the main goal in a late-stage study.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to investigational plozasiran as ...

Sold under the brand names Mounjaro and Zepbound, tirzepatide has been an incredible growth driver for Eli Lilly. In 2022 -- the year it was first approved in the U.S. -- some analysts predicted that ...